Qrons Inc. - SEC Filings

Search Ctrl + K

Qrons Inc.

Biological Products, (no Diagnostic Substances)

OTC.QRON

28-10 Jackson Avenue, #26n, Long Island City, NY, 11101

© 2023 Gheko, Inc. Terms of Service Privacy Policy Browse Companies

Proxies

Information Statement Relating To Certain Shareholder Actions.

News

Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Financial Statements And Exhibits

Changes In Registrant's Certifying Accountant, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Financial Statements And Exhibits

Unregistered Sales Of Equity Securities

Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Financial Statements And Exhibits

Prospectuses and Registrations

Prospectus Filed Pursuant To Rule 424(b)(3).

Post-effective Amendment To An S-1 Or Other Registration Form.

Prospectus Filed Pursuant To Rule 424(b)(3).

Amendment To The S-1 Registration Statement.

Basic Registration Form Used To Register Securities Pursuant To The Securities Act.

Notice Of An Exempt Offering Of Securities Under Regulation D.

Notice Of An Exempt Offering Of Securities Under Regulation D.

Other

Notification Of Inability To Timely File Form 10-q.

Notification Of Late Filing Of Annual 10-k Report.

Notice Of Effectiveness For A Previously Filed Sec Document.

Notice Of Effectiveness For A Previously Filed Sec Document.

Correspondence With The Sec.

Letter From The Sec.

Confidential Treatment Order By The Sec.

Ownership

Amended Statement Of Beneficial Ownership Of More Than 5%.

Amended Statement Of Beneficial Ownership Of More Than 5%.

Financials

Quarterly Filing

Fiscal Year 2023

Quarterly Filing

Quarterly Filing

Quarterly Filing

Fiscal Year 2023